Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by scroll4facts


T.EDT

Pathway Forward

"Top line results for the Company's pivotal Phase III EUPHRATES...

November 11, 2016

T.EDT

RE:RE:Newbies???

Like many other shareholders, I'm still waiting for updates from the...

October 25, 2016

T.EDT

RE:Post-Approval Studies (PAS)

Along with its high safety profile, clinical benefits, and the 5% (up to 18%)...

October 5, 2016

T.EDT

Post-Approval Studies (PAS)

The CEO mentioned the possibility of an Observational Study. Can anyone...

October 5, 2016

T.EDT

MB is only one part of the puzzle

In the document below you'll see that efficacy is only one factor...

October 4, 2016

T.EDT

Trial data submission

How possible is it that the FDA would accept those data to be submitted for...

October 4, 2016

T.EDT

RE:We dared to dream ........

Right.  But we still don't know where this 18% comes from.  Is...

October 3, 2016

T.EDT

RE:Intentionally confusing NR? Where is 176 patient data?...

For sure it is confusing. Is it possible for management to explain all those ...

October 3, 2016

T.EDT

RE:We need to find out more about the 18% mortality benefit

I fully agree. This number is quite significant and could be pointing toward...

October 3, 2016

T.EDT

RE:"Euphoria" and FDA "Compassionate Care"...

Do you think this MB of up to 18% could be within those randomized 176...

October 3, 2016

T.EDT

RE:What is 18% referring to? anyone...

This 18% has to be MB in my opinion since I understand that Toraymyxin can...

October 3, 2016

T.CTX

CTX has a new director

"MISSISSAUGA, ON, Sept. 29, 2016 MISSISSAUGA, ON, Sept. 29, 2016 /CNW/ -...

September 29, 2016

T.EDT

RE:Transcript of Dr. Walker's Rodman & Renshaw conference

If I understand well, the potential targeted market is 150 000 patients/year...

September 29, 2016

T.TST

RE:14c is not enough

"For $42M I would have let go the Belleville plant plus $25M in cash for...

September 27, 2016

T.TST

14c is not enough

Along with many loyal and long term shareholders, I don't agree to this...

September 27, 2016

T.TST

RE:Voting against the 14c acquisition

Typo:  hedge fund

September 18, 2016

T.TST

Voting against the 14c acquisition

I'm going to vote against this 14c "deal" unless the BOD...

September 18, 2016

T.TST

RE:RE:This could turn out very Bad

Correction: I agree.  That's one of the reasons why I believe this...

September 15, 2016

T.TST

RE:This could turn out very Bad

I agree.  That's one of the reasons why I believe this is a weak...

September 15, 2016

T.TST

RE:What a Disaster !!!

Would it be possible for the shareholders to have a complete and...

September 11, 2016

1 2 3 4 5 Next

Featured Company